These data in combination with our data suggesting that CHD4 has a promoting effect on ovarian cancer indicate that DNMT1 is unlikely to be a contributing factor in this context due to its anticarcinogenic effect. The gene discussed is CHD4; the disease is ovarian carcinoma.